GrowingStockReport.com

NASDAQ Decliners Watch List: Novogen Limited (NASDAQ:NVGN) and NuPathe, Inc. (NASDAQ:PATH) Added to Growing Stock Report's NASDAQ Decliners Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 03/27/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Novogen Limited (NASDAQ:NVGN) and NuPathe, Inc. (NASDAQ:PATH).

Novogen Limited (NASDAQ:NVGN) a biotechnology company that engages in the research and development of prescription drugs closed down in its previous session (-9.80%) on 109,510 shares traded. Novogen Limited (NASDAQ:NVGN) is currently down (-56.15%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Novogen Limited (NASDAQ:NVGN)

NuPathe, Inc. (NASDAQ:PATH) a biopharmaceutical company that focuses on the development and commercialization of branded therapeutics for neurological and psychiatric disorders closed down in its previous session (-6.56%) on 367,115 shares traded after NuPathe Announced Fourth Quarter and Full Year 2012 Financial Results and Operational Highlights. NuPathe, Inc. (NASDAQ:PATH) is currently down (-28.1%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about NuPathe, Inc. (NASDAQ:PATH)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com